Of note, heterozygous germline deletion of EPCAM, which causes epigenetic silencing of MSH2, thereby conferring an increased risk of colorectal cancer (65), in addition to biallelic mutation of MSH3, resulting in colorectal cancer (66), has expanded the spectrum of MMR deficient malignancies in humans. Here, EPCAM is linked to colorectal cancer.